Edmond de Rothschild Holding’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-154,160	Closed	-$8.24M	–	724
2020 Q4	$8.24M	Hold	154,160	–	–	0.28%	104
2020 Q3	$6.36M	Buy	154,160 +33,500	+28%	+$1.45M	0.25%	104
2020 Q2	$5.85M	Hold	120,660	–	–	0.24%	116
2020 Q1	$5.1M	Buy	120,660 +48,560	+67%	+$2M	0.27%	107
2019 Q4	$3.08M	Sell	72,100 -33,900	-32%	-$1.47M	0.12%	146
2019 Q3	$3.81M	Sell	106,000 -194,300	-65%	-$5.89M	0.15%	131
2019 Q2	$8.03M	Sell	300,300 -81,700	-21%	-$2.09M	0.3%	84
2019 Q1	$10.3M	Sell	382,000 -30,000	-7%	-$701K	0.35%	74
2018 Q4	$6.66M	Buy	412,000 +2,000	+0.5%	+$38.8K	0.23%	92
2018 Q3	$8.51M	Buy	410,000 +40,548	+11%	+$638K	0.24%	90
2018 Q2	$5.64M	Buy	369,452 +29,452	+9%	+$525K	0.16%	124
2018 Q1	$7.64M	Hold	340,000	–	–	0.22%	104
2017 Q4	$10.2M	Sell	340,000 -125,000	-27%	-$4M	0.3%	88
2017 Q3	$17.5M	Sell	465,000 -10,000	-2%	-$325K	0.5%	63
2017 Q2	$13.2M	Buy	475,000 +158,620	+50%	+$4.73M	0.37%	72
2017 Q1	$10.9M	Buy	316,380 +216,380	+216%	+$7.64M	0.29%	83
2016 Q4	$2.88M	Buy	+100,000	New	+$2.65M	0.08%	168